Streptococcus species, Classification, Structure, Morphology, Biochemical Characteristics, diseases and infection caused by Streptococcus species,Diagnosis and treatment of Streptococcus species,
Babesiosis, caused by infection with intra erythrocytic parasites of the genus Babesia, is one of the most common infections of free living animals worldwide and is gaining increasing interest as an emerging zoonosis in humans. this is a detailed study on this ......considering all the facts such as definition , management, parthenogenesis, diagnosis, treatment, prevention , etc
please comment
thank u
Streptococcus species, Classification, Structure, Morphology, Biochemical Characteristics, diseases and infection caused by Streptococcus species,Diagnosis and treatment of Streptococcus species,
Babesiosis, caused by infection with intra erythrocytic parasites of the genus Babesia, is one of the most common infections of free living animals worldwide and is gaining increasing interest as an emerging zoonosis in humans. this is a detailed study on this ......considering all the facts such as definition , management, parthenogenesis, diagnosis, treatment, prevention , etc
please comment
thank u
Lec 1. introduction to infectious diseaseAyub Abdi
Introduction to the infectious disease, how they transmitt and the stratigies used for the management of infectious disease because it's more in tropical and subtropicals
Bacteriology , Streptococcus species ,strep pyogenes, strep. Pneumoniae and strep fecalis. Diseases cause by Streptococcal microorganisms and how they can be managed. Cultural characteristics and morphology.
Lec 1. introduction to infectious diseaseAyub Abdi
Introduction to the infectious disease, how they transmitt and the stratigies used for the management of infectious disease because it's more in tropical and subtropicals
Bacteriology , Streptococcus species ,strep pyogenes, strep. Pneumoniae and strep fecalis. Diseases cause by Streptococcal microorganisms and how they can be managed. Cultural characteristics and morphology.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. Objectives:
• Describe the morphological and physiological characteristics of genus
Streptococcus
• List the features by which Streptococcus pyogenes, Streptococcus
agalactiae, Viridans Streptococci, and Entrococcus can be identified.
• Describe the spectrum of diseases caused by various Streptococcus.
• Describe different laboratory diagnostic techniques for Sterptococcus.
3.
4.
5. Streptococcaceae
General Characteristics:
• The Streptococcaceae consist of a large family of medically important
species including Streptococcus spp. and Enterococcus spp, many of
these organisms are commonly found as part of normal human flora
• Streptococci are Gram-positive cocci arranged in chains or pairs and
non motile
• Streptococci are catalase negative
6. • This group of organisms are differentiated based on cell wall structure,
hemolytic patterns on blood agar (beta, alpha, or gamma), the reaction
of antibodies to specific bacterial antigen, Lancefield classification
scheme, and , and biochemical identification relating to physiologic
characteristics.
• Most commonly encountered in infections in humans include
Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus
pneumoniae, Enterococcus faecalis, and the viridans streptococci
group.
7. Streptococci classification:
➢According to hemolysis: Some streptococcal species can completely
hemolyze red blood cells, while other species partially hemolyze the
RBC’s, therefore Streptococci are divided into 3 groups based on their
hemolytic ability.
▪ Beta hemolytic streptococci:
Completely lyse the RBCs, leaving a clear zone
of hemolysis around the colonies.
▪ Alpha hemolytic streptococci: Partially lyse
the RBCs, leaving greenish coloration surrounding the colonies.
▪ Gamma hemolytic (non-hemolytic) streptococci:
They cannot lyse the RBCs
8. ➢According to carbohydrates antigens on the cell wall:
These antigens are called Lancefield antigens, and they are given letter names (A-
H, and K-U) is used to divide streptococci into stereological group Lancefield
groups. Typing is done only for A, B,C,F and G. group A or S.pyogenes is the most
important as it causes several human diseases
9. Streptococcus pyogenes
Group A Streptococci (Beta hemolytic)
• Rosenbach (1884) isolated the cocci from human suppurative lesions
and gave them the name Streptococcus pyogenes.
Normal habitat:
S. pyogenes may be carried in the upper respiratory tract of humans, it is
not considered to be normal flora and should be deemed clinically
important whenever it is encountered
Mode of transmission:
Direct contact: person to person
Indirect contact: aerosolized droplets from coughs or sneezes
10. Virulence factors:
▪ M-Protein: antiphagocytic
▪ Protein F mediates epithelial cell attachment (fibronectin-binding)
▪ Pyrogenic exotoxin:
• Pyrogenic exotoxin A (erythrogenic toxin ) This is a toxin
produced by group A streptococci, and it causes scarlet fever
• Pyrogenic exotoxin B: destroy tissue(necrotizing)
Pathogenicity
11. ➢Enzymes:
▪ Haemolysins: there are two types
Streptolysin S: It is oxygen stable, also responsible of beta
hemolysis, but it is not immunogenic capable of lysing erythrocytes,
leukocytes, and platelets in the presence of oxygen.
Streptolysin O: This is oxygen labile enzyme(is broken down by
oxygen), capable of lysing the erythrocytes, leukocytes, and platelets,
and will produce haemolysis only in the absence of oxygen It is
immunogenic after infection anti-streptolysin O antibodies were
developed.
12. Diseases and infections:
➢Pyogenic local infections:
• Streptococcal throat infection or pharyngitis: enlarged
tonsils with purulent exudate. Pyoderma (impetigo): skin
infection characterized by the formation of blisters
➢Invasive disease:
• Acute bacterial endocarditis
• Puerperal sepsis infection of the uterus after delivery
associated with septicemia
13. ➢Toxigenic disease:
• Scarlet fever in children associated with pharyngitis and
rash due to erythrogenic toxin
• Streptococcus toxic shock syndrome
➢Post streptococcal immunogenic infection:
• Acute rheumatic fever (Cross-reactions of antibodies
produced against streptococcal antigens and human heart
tissue)
• Acute glomerulonephritis (Deposition of antibody-
streptococcal antigen complexes in the kidney)
14. Identification:
❖Specimens according to the site of infection
• Blood for blood culture (bacteriemia, septicemia, and endocarditis)
• Throat swab from the lesion (pus)
❖Antigen detection test: using Enzyme-linked immunosorbent
assay(ELISA) or agglutination test.
❖Serological test: Antistreptolysin O (ASO) titer is high soon after
group A streptococcal infection. An elevated ASO titer of more than
200 units indicates a recent streptococcal infection
15. ❖ Cultural characteristics:
Culture media:
• Culture on blood agar, chocolate blood agar
• Selective media crystal violet blood agar
Incubation condition optimum temperature 37°C. they are aerobic
bacteria or facultative anaerobic.
Colonial appearance:
• On blood agar colonies show complete hemolysis(Beta
hamolysis).
16. Biochemical reactions:
▪ Catalase negative
▪ Bacitracin sensitivity test: sensitive to bacitracin
Treatment: Penicillin G is the drug of choice if the patient has an
allergy to clindamycin or erythromycin is used
17. Group B streptococci (streptococcus agalactiae)
Normal habitat:
Inhibit about 25% of the normal adult vaginaand lower gastrointestinal tract
Mode of transmission:
• Endogenous strain: gaining access to the sterile site(s) probable
• Direct contact: person to person from mother in utero or during delivery
• Nosocomial transmission by unwashed hands of mother or health care
personnel
18. Pathogenicity:
Virulence factors:
Uncertain; capsular material interferes with phagocytic activity
Diseases and infection:
• Neonatal meningitis, pneumonia, and septicemia (infants can acquire
S.agalactiae during delivery )
• Pneumonia and endocarditis (in adult)
19. Identification:
• Specimens Vaginal Swab, blood, CSF, ear swab
• Beta hemolytic on blood agar
• Bacitracin resist
• Hydrolyses Hippurate and are CAMP factor positive
20. Streptococcus pneumoniae
Alpha hemolytic (No Lancefield antigen)
Morphology: Gram positive cocci arranged in pairs (diplococci),have
lancet shape (fusiform pointed ends) they are capsulated, capsules may
appear as unstained haloes around the organism
Inhabitant: normally carried in upper respiratory tract of healthy
persons
21. Pathogenicity:
Virulence factors:
• The major virulence factor of S. pneumonia is its polysaccharide
capsule which protects the bacteria from phagocytosis.
• secretory IgA protease
Diseases and infection:
• Bacterial pneumonia
• Meningitis
• Sinusitis and otitis media
22. Viridans streptococci (Alpha hemolytic)
• This is a large group with no Lancefield antigen, including S.
mutans, S.mitis.
• Inhabitant: They are normal flora of the oral cavity,
gastrointestinal tract, and female genital tract
23. • Pathogenicity :
• Virulence factors: Generally considered to be of low virulence;
• production of extracellular complex polysaccharides (e.g., glucans and
dextrans) enhances attachment to host cell surfaces, such as cardiac
endothelial cells or tooth surfaces in the case of dental caries
• Diseases and infection: dental infections and endocarditis.
24. Identification of Streptococcus pneumoniae and Viridans streptococci
• Both are alpha-hemolytic
• Differentiated by: Bile solubility test and optochin disc sensitivity
test
• Streptococcus pneumoniae: soluble in bile, sensitive to optochin
antibiotic disc.
• Viridans streptococci: not soluble in bile, resist optochin antibiotic
disc
25. Group D streptococci
(Entrococci and non-entrococci)
• These are alpha-hemolytic, eg. Enterococcus faecalis
Inhabitant: It is a normal flora of the intestine
Pathogenicity :
• Virulence factors:
• Adhesions, cytolysins, and other metabolic capabilities may allow these
organisms to proliferate as nosocomial/healthcare-associated pathogens
• Diseases and infection:
• Most infections are healthcare–associated and include urinary tract
infection, wound infection, and endocarditis.,
26. Identification:
• Grow in MacConkey gives pink colonies, and it can grow in the
presence of 40% bile. grow in 6.5% NaCl
• Hydrolyze polysaccharide esculin(bile esculin positive)
27. Questions
➢Describe Morphology & physiological characteristics of Streptococcus?
➢Classify the streptococcus on the basis of Hemolysis?
➢Describe medically important Streptococci & their characteristics?
➢Describe Lab Diagnosis of Streptococci?
➢Differentiate between Streptococci and Staphylococci?
➢List virulence factors or Streptococci?
➢Group D streptococci is ……………hemolytic.
➢Viridans streptococci is …………hemolytic.
➢Why streptolysin S cannot be used for diagnosis?
➢How can we differentiate between Streptococcus pneumoniae and Viridans
streptococci?
➢25% of women carry this type of Streptococci in their reproductive
systems ?………………….
➢……………Streptococci cause similar infections as Staphylococcus aureus?